Jagsonpal Pharmaceuticals

quarterly
yearly
ParticularsSep '24Dec '24Mar '25Jun '25Sep '25
Revenue76.3476.3561.3378.4477.50
Expenses60.9860.8652.4164.0060.69
EBITDA17.9418.1511.4917.0419.47
EBIT15.6038.938.9714.6817.08
Profit Before Tax15.3738.678.7114.4416.81
Net Profit11.4631.996.5810.8012.57
Financial Ratios
Operating Profit Margin24.02%55.84%19.25%22.54%26.13%
Net Profit Margin15.34%18.42%11.51%14.28%16.88%
Earning Per Share (Diluted)1.704.740.981.581.87
Dividends Per Share0.000.000.000.000.00